» Articles » PMID: 31853280

Novel Detachable Stents for the Treatment of Benign Esophageal Strictures

Overview
Journal Exp Ther Med
Specialty Pathology
Date 2019 Dec 20
PMID 31853280
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

The radial force of esophageal stents may not completely change during extraction and therefore, the procedure of stent removal may cause tissue damage. The present study reports the manufacture of 2 novel detachable stents, which were designed to reduce tissue damage through their capacity to be taken or fall apart prior to removal and evaluated the supporting properties of these stents and the extent of local mucosal injury during their removal. The stents were manufactured by braiding, heat-setting, coating and connecting. The properties of the stents were evaluated by determining the following parameters: Expansion point, softening point, stent flexibility, radial compression ratio and radial force. A total of 18 rabbits with induced esophageal stricture were randomly assigned to 3 groups as follows: Detachable stent (DS) group, biodegradable stent (BS) group and control group. The stricture rate, complications, survival, degradation and stent removal were observed over 8 weeks. The stents of the DS and BS groups provided a similar supporting effect. The stricture rate, incidence of complications and survival were also similar between the 2 groups, while significant differences were noted between the DS and control groups and between the BS and control groups. In the BS group, the stents were degraded and moved to the stomach within 7 weeks (2 in 6 weeks and 3 in 7 weeks). The debris was extracted using biopsy forceps. In the DS group, all stents were easy to remove and 2 cases exhibited minor hemorrhage. In conclusion, the 2 types of novel detachable stent provided an equally efficient supporting effect and and may reduce the incidence of secondary injury during stent removal.

Citing Articles

Nanotechnology-based biomedical devices in the cancer diagnostics and therapy.

Tantray J, Patel A, Parveen H, Prajapati B, Prajapati J Med Oncol. 2025; 42(2):50.

PMID: 39828813 DOI: 10.1007/s12032-025-02602-x.


Advances in the Prevention and Treatment of Esophageal Stricture after Endoscopic Submucosal Dissection of Early Esophageal Cancer.

Zhang Y, Zhang B, Wang Y, Zhang J, Wu Y, Xiao T J Transl Int Med. 2020; 8(3):135-145.

PMID: 33062589 PMC: 7534493. DOI: 10.2478/jtim-2020-0022.

References
1.
Yamashina T, Uedo N, Fujii M, Ishihara R, Mikamori M, Motoori M . Delayed perforation after intralesional triamcinolone injection for esophageal stricture following endoscopic submucosal dissection. Endoscopy. 2013; 45 Suppl 2 UCTN:E92. DOI: 10.1055/s-0032-1326253. View

2.
Tanaka T, Takahashi M, Nitta N, Furukawa A, Andoh A, Saito Y . Newly developed biodegradable stents for benign gastrointestinal tract stenoses: a preliminary clinical trial. Digestion. 2007; 74(3-4):199-205. DOI: 10.1159/000100504. View

3.
Shah J . Benign refractory esophageal strictures: widening the endoscopist's role. Gastrointest Endosc. 2005; 63(1):164-7. DOI: 10.1016/j.gie.2005.08.033. View

4.
El Hajj I, Imperiale T, Rex D, Ballard D, Kesler K, Birdas T . Treatment of esophageal leaks, fistulae, and perforations with temporary stents: evaluation of efficacy, adverse events, and factors associated with successful outcomes. Gastrointest Endosc. 2013; 79(4):589-98. DOI: 10.1016/j.gie.2013.08.039. View

5.
van Hooft J, van Berge Henegouwen M, Rauws E, Bergman J, Busch O, Fockens P . Endoscopic treatment of benign anastomotic esophagogastric strictures with a biodegradable stent. Gastrointest Endosc. 2011; 73(5):1043-7. DOI: 10.1016/j.gie.2011.01.001. View